Gastro Medical News about Gastroesophageal Reflux Disease

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy of Esophageal Impedance/pH Monitoring in Patients With Refractory Gastroesophageal Reflux Disease, on and off Therapy
Clinical Gastroenterology and Hepatology , 07/10/09

Pritchett JM et al. - Abnormal impedance in patients on therapy predicts acid reflux in patients off therapy. In patients with refractory reflux, combined impedance/pH monitoring might provide the single best strategy for evaluation of reflux symptoms.

<< Previous
Hepatitis B Seroprevalence and Disease Characteristics in an...

Next >>
Detection and grading for esophageal varices in patients with...

Gastroesophageal Reflux Might Cause Esophagitis Through a Cytokine-Mediated Mechanism Rather Than Caustic Acid Injury
Gastroenterology, 10/28/09 Relevance Score: 81%

Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey
Digestive Diseases and Sciences, 10/27/09 Relevance Score: 81%

Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease with impedance monitoring
Surgical Endoscopy, 11/16/09 Relevance Score: 80%

XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09 Relevance Score: 80%

Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)
Inflammation & Allergy - Drug Targets, 10/12/09 Relevance Score: 80%